Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.

Haolin LiuKatja AviszusPearlanne ZelarneyShu-Yi LiaoAnthony N GerberBarry J MakeMichael E WechslerPhilippa MarrackR Lee Reinhardt

Published in: ERJ open research (2023)

Deep immune phenotyping of the SARS-CoV-2 vaccine response revealed the complex nature of vaccine-elicited immunity and highlights the need for more personalised vaccination schemes in patients with underlying lung conditions.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
single cell
patient reported